advertisement
ATC Level5: G04CB02 - Dutasteride
ATC Level1:
- G - Genito urinary system and sex hormones
ATC Level2:
ATC Level3:
- G04C - Drugs used in benign prostatic hypertrophy
ATC Level4:
ATC Level5:
Drugs in ATC category "G04CB02":
- Afdura
- Avidart
- Avodart
- Dutasteride belongs to a class of medications known as 5-alpha-reductase inhibitors . It is used to relieve symptoms of benign prostatic hyperplasia (BPH) in men with enlarged prostates. BPH is a noncancerous enlargement of the prostate gland that usually occurs in men after the age of 50. Dutasteride works to reduce the production of dihydrotestosterone (DHT), a hormone that causes enlargement of the prostate gland. Dutasteride relieves symptoms of BPH by reducing the size of the prostate...
- Duagen
- Duprost
- Dutagen
- Dutalfa
- Dutas
- Dutasteride (Dutasteride)
- Indications and Usage, Limitations of Use (1.3) June 2011 Warnings and Precautions, Increased Risk of High-grade Prostate Cancer (5.2) June 2011 1 INDICATIONS AND USAGE AVODART is a 5 alpha-reductase inhibitor indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: (1.1) ...
- Eldart
- Pharmacological action Eldart is a drug for the treatment of benign prostatic hyperplasia. It inhibits the activity of isoenzymes of 5a-reductase type 1 and 2 are responsible for the conversion of testosterone to 5a-dihydrotestosterone. DHT is the primary androgen responsible for hyperplasia of the glandular tissue of the prostate gland. The maximum effect of Eldart on the reduction of the concentration of DHT is dose dependent and is observed in 1-2 weeks after starting treatment. After...
- Sterdu
- Veltride
- Zyfetor
advertisement
The information was verified by Dr. Rachana Salvi, MD Pharmacology
© 2002 - 2024 "sdrugs.com". All Rights Reserved